Health Service Executive. (2014) Health Service performance assurance report July 2014. Dublin: Health Service Executive.
Preview | Title | Contact |
---|---|---|
|
PDF (HSE performance assurance July 2014)
1MB | |
|
PDF (HSE management data July 2014)
1MB |
The HSE's Performance Assurance Report (PAR) provides an overall analysis of key performance data from Divisions, such as Acute, Mental Health, Social Care, Primary Care, Health and Wellbeing as well as Finance and HR. The activity data reported is based on Performance Activity and Key Performance Indicators outlined in the current National Service Plan.
Addiction services (p.30)
• 9,283 patients received Opioid Substitute Treatment (excluding prisons) at the end of the reporting period which includes 3,875 patients being treated by 336 GPs in the community.
• Opioid Substitute Treatment was dispensed by 612 pharmacies catering for 6,292 patients at the end of the reporting period.
• At the end of the reporting period there were 72 HSE clinics providing Opioid Substitute Treatment and an additional 10 clinics were provided in the prison service.
• 72 new patients commenced Opioid Substitute Treatment during the reporting period (8 in General Practice, 49 in HSE clinics and 15 in the prison clinics)
Tobacco control (p.33)
The number of smokers who received intensive cessation support from a cessation counsellor had an expected activity of 5,639 year to date July 2014. The reported activity year to date for July is 5,357 which is 5% less then what would be expected compared to last year’s figures. Throughput to services generally falls during the summer months; however the service is operating on target overall.
Performance against expected activity for the training of front line workers in brief intervention in smoking cessation is 14.8% ahead of target (819 staff trained versus an expected activity target of 713), however releasing staff for training in some areas is challenging. (Please note there are six outstanding returns due to annual leave which will be provided in due course.)
Details of expenditure on methadone and other schemes may be found in the data management report (p.80)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Health care delivery
J Health care, prevention, harm reduction and treatment > Health care administration > Health care quality control
J Health care, prevention, harm reduction and treatment > Health care economics
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page